Managing Multiorgan Failure in Acute on Chronic Liver Failure

E Pompili, G Iannone, D Carrello… - Seminars in Liver …, 2024 - thieme-connect.com
Acute-on-chronic liver failure (ACLF) is defined as a clinical syndrome that develops in
patients with chronic liver disease characterized by the presence of organ failure and high …

Myosteatosis and the clinical outcomes of patients with liver cirrhosis: A meta-analysis

H Xue, Y Liu, Y Liu, H Li, Q Liang, L Ma, J Liu, M Zhao - Plos one, 2024 - journals.plos.org
Objectives This study aimed to examine the potential correlation between myosteatosis and
the prognosis of patients diagnosed with liver cirrhosis by a meta-analysis. Methods Cohort …

Scoparone alleviates nonalcoholic fatty liver disease by modulating the PPARα signaling pathway

P Huang, L Yang, T Liu, Y Jiang, Z Chen… - European Journal of …, 2024 - Elsevier
Scoparone (Scop), a natural compound derived from Artemisia capillaris Thunb, has
demonstrated efficacy in improving nonalcoholic fatty liver disease (NAFLD). This study aims …

Skeletal muscle density as a new predictor of abdominal infection in abdominal trauma patients

F Xi, N Zheng, B Xiong, D Wang, R Teng, X Zhang… - Clinical Nutrition, 2024 - Elsevier
Background and aims Skeletal muscle density (SMD) is a valuable prognostic indicator in
various conditions such as cancer, liver cirrhosis. Yet, the connection between SMD and …

Factors Influencing Immunotherapy Outcomes in Cancer: Sarcopenia and Systemic Inflammation

E Ucgul, DC Guven, AN Ucgul, Y Ozbay… - Cancer …, 2024 - journals.sagepub.com
Background Immunotherapy has shown promise in treating various subtypes of metastatic
cancers, but many patients are frail and may have compromised immune systems, which …

[PDF][PDF] What references and what gold standard should be used to assess myosteatosis in chronic liver disease?

G Henin, N Lanthier - Journal of Hepatology, 2024 - dial.uclouvain.be
We read Simone Di Cola's recent manuscript [1] with interest. The authors use abdominal
computed tomography (CT) scans to analyze muscle changes in cirrhotic patients [1]. This is …

AI model using CT-based imaging biomarkers to predict hepatocellular carcinoma in patients with chronic hepatitis B

H Shin, MH Hur, BG Song, SY Park, GA Kim… - Journal of …, 2024 - Elsevier
Background & aims Various hepatocellular carcinoma (HCC) prediction models have been
proposed for patients with chronic hepatitis B (CHB) using clinical variables. We aimed to …

[HTML][HTML] Ultrasound Assessment of Sarcopenia in Alcoholic Liver Disease

VT Enciu, PM Ologeanu, C Fierbinteanu-Braticevici - Diagnostics, 2024 - mdpi.com
Malnutrition frequently affects patients with alcoholic liver disease (ALD), with important
impacts on disease prognosis. Sarcopenia, the clinical phenotype of malnutrition …

[HTML][HTML] Strength in quality: Myosteatosis as a predictor of survival in advanced hepatocellular carcinoma

C Campani, A Berzigotti - United European gastroenterology …, 2024 - pmc.ncbi.nlm.nih.gov
Strength in quality: Myosteatosis as a predictor of survival in advanced hepatocellular
carcinoma - PMC Skip to main content Here's how you know Official websites use .gov A .gov …

Comment on 'Myosteatosis and Muscle Loss Impact Liver Transplant Outcomes in Male Patients With Hepatocellular Carcinoma'by Lu et al

A Kamiliou, V Lekakis, G Xynos… - Journal of Cachexia …, 2024 - pmc.ncbi.nlm.nih.gov
Comment on ‘Myosteatosis and Muscle Loss Impact Liver Transplant Outcomes in Male
Patients With Hepatocellular Carcinoma’ by Lu et al - PMC Skip to main content Here's how you …